Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease

AimsEpidemiological evidence for the link of interleukin 1 (IL-1) and its inhibition with cardiovascular diseases (CVDs) remains controversial. We aim to investigate the cardiovascular effects of IL-1 receptor antagonist (IL-1Ra) and underlying mechanisms.MethodsGenetic variants identified from a ge...

全面介绍

书目详细资料

发表在:	Frontiers in Endocrinology
Main Authors:	Fangkun Yang, Ning Huangfu, Jiaxi Shen, Pengpeng Su, Lujie Zhu, Hanbin Cui, Shuai Yuan
格式:	文件
语言:	英语
出版:	Frontiers Media S.A. 2023-10-01
主题:	apolipoprotein B interleukin 1 receptor antagonist coronary heart disease myocardial infarction lifestyle modification
在线阅读:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1278273/full